Redox cycling-based amplifying electrochemical sensor for in situ clozapine antipsychotic treatment monitoring

Electrochimica Acta

Volumn 130, Issue , 2014, Pages 497-503

  Ben Yoav, Hadar ^a   Winkler, Thomas E ^a   Kim, Eunkyoung ^b   Chocron, Sheryl E ^a   Kelly, Deanna L ^c   Payne, Gregory F ^a,b   Ghodssi, Reza ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Amplifier; Antipsychotic drug; Clozapine; Electrochemical biochip; Redox cycling

Indexed keywords

AMPLIFIERS (ELECTRONIC); BIOCHIPS; CHITOSAN; DISEASES; ELECTROCHEMICAL OXIDATION; PHENOLS; SENSORS;

ADVERSE SIDE EFFECTS; ANTIPSYCHOTIC DRUG; CLOZAPINE; ELECTROCHEMICAL BIOCHIPS; MICRO-SYSTEM TECHNOLOGIES; PERSONALIZED MEDICINES; REDOX CYCLING; TREATMENT MONITORING;

SIGNAL DETECTION;

EID: 84897492135     PISSN: 00134686     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.electacta.2014.03.045     Document Type: Article

References (77)

1. E.Q. Wu, H.G. Birnbaum, L. Shi, D.E. Ball, R.C. Kessler, M. Moulis, and J. Aggarwal The economic burden of schizophrenia in the United States in 2002 J. Clin. Psychiatry 66 2005 1122
2. R.W. Buchanan, J. Kreyenbuhl, D.L. Kelly, J.M. Noel, D.L. Boggs, B.A. Fischer, S. Himelhoch, B. Fang, E. Peterson, P.R. Aquino, and W. Keller The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements Schizophr. Bull. 36 2010 71
3. R.A. Carlstedt Handbook of Integrative Clinical Psychology, Psychiatry, and Behavioral Medicine: Perspectives, Practices, and Research 2010 Springer Publishing Company New York, USA
4. B.J. Sadock, H.I. Kaplan, and V.A. Sadock Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry 10th ed. 2007 Lippincott Williams & Wilkins Philadelphia, PA
5. J.M. Azorin, R. Spiegel, G. Remington, J.M. Vanelle, J.J. Pere, M. Giguere, and I. Bourdeix A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia Am. J. Psychiat. 158 2001 1305
6. A. Breier, R.W. Buchanan, B. Kirkpatrick, O.R. Davis, D. Irish, A. Summerfelt, and W.T. Carpenter Jr. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia Am. J. Psychiat. 151 1994 20
7. R.R. Conley, C.A. Tamminga, D.L. Kelly, and C.M. Richardson Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response Biol. Psychiatry 46 1999 73
8. J. Kane, G. Honigfeld, J. Singer, and H. Meltzer Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine Arch. Gen. Psychiatry 45 1988 789
9. D.L. Kelly, J. Kreyenbuhl, R.W. Buchanan, and A.K. Malhotra Why not clozapine? Clin. Schizophr. Relat Psychoses 1 2007 92
10. J. Volavka, P. Czobor, B. Sheitman, J.P. Lindenmayer, L. Citrome, J.P. McEvoy, T.B. Cooper, M. Chakos, and J.A. Lieberman Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder Am. J. Psychiat. 159 2002 255
11. J. Fitzsimons, M. Berk, T. Lambert, M. Bourin, and S. Dodd A review of clozapine safety Expert Opin. Drug Saf. 4 2005 731
12. Novartis, Clozaril, http://www.clozaril.com/.
13. D.J. Freeman, and L.K. Oyewumi Will routine therapeutic drug monitoring have a place in clozapine therapy? CPK 32 1997 93
14. C. Haring, U. Meise, C. Humpel, A. Saria, W.W. Fleischhacker, and H. Hinterhuber Dose-related plasma levels of clozapine: Influence of smoking behaviour, sex and age Psychopharmacology 99 1989 S38
15. M. Hasegawa, R. Gutierrez-Esteinou, L. Way, and H.Y. Meltzer Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: Effect of smoking J. Clin. Psychopharmacology 13 1993 383
16. P.J. Perry, K.A. Bever, S. Arndt, and M.D. Combs Relationship between patient variables and plasma clozapine concentrations: A dosing nomogram Biol. Psychiatry 44 1998 733
17. A. Stark, and J. Scott A review of the use of clozapine levels to guide treatment and determine cause of death Aust. NZ. J. Psychiat. 46 2012 816
18. B. Warner, L. Alphs, J. Schaedelin, and T. Koestler Clozapine and sudden death Lancet 355 2000 842
19. R.R. Conley, D.L. Kelly, T.J. Lambert, and R.C. Love Comparison of clozapine use in Maryland and in Victoria, Australia Psychiatr. Serv. 56 2005 320
20. D.L. Kelly, L.B. Dixon, J.A. Kreyenbuhl, D. Medoff, A.F. Lehman, R.C. Love, C.H. Brown, and R.R. Conley Clozapine utilization and outcomes by race in a public mental health system: 1994-2000 J. Clin. Psychiat. 67 2006 1404
21. J. Kreyenbuhl, M. Valenstein, J.F. McCarthy, D. Ganoczy, and F.C. Blow Long-term combination antipsychotic treatment in VA patients with schizophrenia Schizophr. Res. 84 2006 90
22. J.A. Lieberman Maximizing clozapine therapy: Managing side effects J. Clin. Psychiat. 59 1998 38
23. J.B. Mallinger, S.G. Fisher, T. Brown, and J.S. Lamberti Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia Psychiatr. Serv. 57 2006 133
24. D.M. Taylor, C. Young, and C. Paton Prior antipsychotic prescribing in patients currently receiving clozapine: A case note review J. Clin. Psychiat. 64 2003 30
25. E.M. Weissman Antipsychotic prescribing practices in the veterans healthcare administration-New York metropolitan region Schizophrenia Bull. 28 2002 31
26. O. Agid, G. Foussias, S. Singh, and G. Remington Where to position clozapine: Re-examining the evidence Can. J. Psychiat. 55 2010 677
27. R. Kerwin When should clozapine be initiated in schizophrenia?.: Some arguments for and against earlier use of clozapine CNS Drugs 21 2007 267
28. J. Wang Amperometric biosensors for clinical and therapeutic drug monitoring: A review J. Pharmaceut. Biomed. 19 1999 47
29. J. Wang Electrochemical biosensors: Towards point-of-care cancer diagnostics Biosens. Bioelectron. 21 2006 1887
30. M.U. Ahmed, M.M. Hossain, and E. Tamiya Electrochemical biosensors for medical and food applications Electroanalysis 20 2008 616
31. K. Farhadi, and A. Karimpour Electrochemical behavior and determination of clozapine on a glassy carbon electrode modified by electrochemical oxidation Anal. Sci. 23 2007 479
32. J.M. Kauffmann, G.J. Patriarche, and G.D. Christian Electrochemical oxidation of derivatives of dibenzodiazepin. Dibenzothiazepin and dibenzoxazepin Anal. Lett. 12 1979 1217
33. E. Akam, and P.G. Strange Inverse agonist properties of atypical antipsychotic drugs Biochem. Pharmacol. 67 2004 2039
34. A.S. Al Attas Novel PVC membrane selective electrode for the determination of clozapine in pharmaceutical preparations Int. J. Electrochem. Sci 4 2009 9
35. T. Alizadeh, and M. Akhoundian A novel potentiometric sensor for promethazine based on a molecularly imprinted polymer (MIP): The role of MIP structure on the sensor performance Electrochim. Acta 55 2010 3477
36. T. Alizadeh, M.R. Ganjali, and M. Akhoundian Synthesis and application of different nano-sized imprinted polymers for the preparation of promethazine membrane electrodes and comparison of their efficiencies Int. J. Electrochem. Sci. 7 2012 7655
37. M. Antonini, P. Ghisellini, L. Pastorino, C. Paternolli, and C. Nicolini Preliminary electrochemical characterisation of cytochrome P4501A2-clozapine interaction IEE Proc. -Nanobiotechnol. 150 2003 31
38. B. Blankert, O. Dominguez, W. El Ayyas, J. Arcos, and J.-M. Kauffmann Horseradish peroxidase electrode for the analysis of clozapine Anal. Lett. 37 2005 903
39. U. Bondesson, and L.H. Lindström Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection Psychopharmacology 95 1988 472
40. K. Farhadi, M. Bahram, D. Shokatynia, and F. Salehiyan Optimization of polymeric triiodide membrane electrode based on clozapine-triiodide ion-pair using experimental design Talanta 76 2008 320
41. S.E. Haas, L. Brum, C. de Andrade, F.J. Azeredo, M. Pigatto, B.G. Silva Torres, S.S. Guterres, and T.D. Costa Highly sensitive LC-MS/MS method for the determination of clozapine in rat plasma: Application to a preclinical pharmacokinetic study J. Liq. Chromatogr. R. T. 35 2012 2873
42. E. Hammam, A. Tawfik, and M.M. Ghoneim Adsorptive stripping voltammetric quantification of the antipsychotic drug clozapine in bulk form, pharmaceutical formulation and human serum at a mercury electrode J. Pharmaceut. Biomed. 36 2004 149
43. L. Hernandez, E. Gonzalez, and P. Hernandez Determination of clozapine by adsorptive anodic voltammetry using glassy carbon and modified carbon paste electrodes Analyst 113 1988 1715
44. S. Hillaert, L. Snoeck, and W. Van den Bossche Optimization and validation of a capillary zone electrophoretic method for the simultaneous analysis of four atypical antipsychotics J. Chromatogr. A 1033 2004 357
45. F. Huang, S. Qu, S. Zhang, B. Liu, and J. Kong Sensitive detection of clozapine using a gold electrode modified with 16-mercaptohexadecanoic acid self-assembled monolayer Talanta 72 2007 457
46. C. Humpel, C. Haring, and A. Saria Rapid and sensitive determination of clozapine in human plasma using high-performance liquid chromatography and amperometric detection J. Chromatogr. 491 1989 235
47. T.B. Jarbawi, and W.R. Heineman Preconcentration of tranquilizers by adsorption/extraction at a wax-impregnated graphite electrode Anal. Chim. Acta 186 1986 11
48. T.A. Jennison, P. Brown, J. Crossett, M. Kushnir, and F.M. Urry A rapid gas chromatographic method quantitating clozapine in human plasma or serum for the purpose of therapeutic monitoring J. Anal. Toxicol. 19 1995 537
49. W. Jin, Q. Xu, and W. Li Determination of clozapine by capillary zone electrophoresis following end-column amperometric detection with simplified capillary/electrode alignment Electrophoresis 21 2000 1415
50. M.H. Mashhadizadeh, and E. Afshar Electrochemical investigation of clozapine at TiO2 nanoparticles modified carbon paste electrode and simultaneous adsorptive voltammetric determination of two antipsychotic drugs Electrochim. Acta 87 2013 816
51. S.A. Mohajeri, G. Karimi, J. Aghamohammadian, and M.R. Khansari Clozapine recognition via molecularly imprinted polymers; Bulk polymerization versus precipitation method J. Appl. Polym. Sci. 121 2011 3590
52. C. Paternolli, M. Antonini, P. Ghisellini, and C. Nicolini Recombinant cytochrome P450 immobilization for biosensor applications Langmuir 20 2004 11706
53. J. Sekula, J. Everaert, H. Bohets, B. Vissers, M. Pietraszkiewicz, O. Pietraszkiewicz, F. Du Prez, K. Vanhoutte, P. Prus, and L.J. Nagels Coated wire potentiometric detection for capillary electrophoresis studied using organic amines, drugs, and biogenic amines Anal. Chem. 78 2006 3772
54. E.A. Taha, S.M. Soliman, H.E. Abdellatef, and M.M. Ayad Colorimetric methods for the determination of some tricyclic antidepressant drugs in their pure and dosage forms Microchim. Acta 140 2002 175
55. R. Uřinovská, H. Brozmanová, P. Šiš tík, P. Šilhán, I. Kacířová, K. Lemr, and M. Grundmann Liquid chromatography - tandem mass spectrometry method for determination of five antidepressants and four atypical antipsychotics and their main metabolites in human serum J. Chromatogr. B 907 2012 101
56. D. Yu, B. Blankert, E. Bodoki, S. Bollo, J.-C. Viré, R. Sandulescu, A. Nomura, and J.-M. Kauffmann Amperometric biosensor based on horseradish peroxidase-immobilised magnetic microparticles Sensor. Actuat. B: Chem. 113 2006 749
57. D. Yu, B. Blankert, and J.-M. Kauffmann Development of amperometric horseradish peroxidase based biosensors for clozapine and for the screening of thiol compounds Biosens. Bioelectron. 22 2007 2707
58. S.T. Koev, P.H. Dykstra, X. Luo, G.W. Rubloff, W.E. Bentley, G.F. Payne, R. Ghodssi, and Chitosan: An integrative biomaterial for lab-on-a-chip devices Lab Chip 10 2010 3026
59. Y. Liu, X.W. Shi, E. Kim, L.M. Robinson, C.K. Nye, R. Ghodssi, G.W. Rubloff, W.E. Bentley, and G.F. Payne Chitosan to electroaddress biological components in lab-on-a-chip devices Carbohyd. Polym. 84 2011 704
60. K.M. Gray, E. Kim, L.-Q. Wu, Y. Liu, W.E. Bentley, and G.F. Payne Biomimetic fabrication of information-rich phenolic-chitosan films Soft Matter 7 2011 9601
61. E. Kim, T. Gordonov, W.E. Bentley, and G.F. Payne Amplified and in situ detection of redox-active metabolite using a bio-based redox-capacitor Anal. Chem. 85 2013 2102
62. E. Kim, T. Gordonov, Y. Liu, W.E. Bentley, and G.F. Payne Reverse engineering to suggest biologically-relevant redox activities of phenolic materials ACS Chem. Biol. 8 2013 716
63. E. Kim, Y. Liu, X.-W. Shi, X. Yang, W.E. Bentley, and G.F. Payne Biomimetic approach to confer redox activity to thin chitosan films Adv. Funct. Mater. 20 2010 2683
64. G.F. Payne, Y. Liu, and E. Kim Novel approach for generating an electrochemically active film with amplification, switching and diode-like behavior ISDRS '09. International Semiconductor Device Research Symposium College Park, Maryland, United States, 9-11 December 2009 1
65. R. Fernandes, L.-Q. Wu, T. Chen, H. Yi, G.W. Rubloff, R. Ghodssi, W.E. Bentley, and G.F. Payne Electrochemically induced deposition of a polysaccharide hydrogel onto a patterned surface Langmuir 19 2003 4058
66. A.J. Bard, and L.R. Faulkner Electrochemical Methods: Fundamentals and Applications 2nd ed. 2001 John Wiley & Sons Inc New York
67. L. Couchman, P.E. Morgan, E.P. Spencer, and R.J. Flanagan Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: Data from a therapeutic drug monitoring service, 1993-2007 Ther. Drug Monit. 32 2010 438
68. H. Ben-Yoav, S.E. Chocron, T.E. Winkler, E. Kim, D.L. Kelly, G.F. Payne, and R. Ghodssi The effect of vitamin C in point-of-care blood analysis using an electrochemical biosensor IEEE Sensors 2013 Baltimore, Maryland, United States, 3-6 November 2013 141
69. M.I. Temkin, and V. Pyzhev Kinetics of ammonia synthesis on promoted iron catalysts Acta Physicochim. URSS 12 1940 217
70. H. Ben-Yoav, T.E. Winkler, E. Kim, D.L. Kelly, G.F. Payne, and R. Ghodssi Catechol-modified chitosan system as a bio-amplifier for schizophrenia treatment analysis 2013 MRS Spring Meeting San Francisco, California, United States, 1-5 April 2013
71. H. Ben-Yoav, T.E. Winkler, S.E. Chocron, S. Restaino, G. Costa, E. Kim, D.L. Kelly, G.F. Payne, and R. Ghodssi Bio-amplifying lab-on-a-chip for antipsychotic clozapine treatment monitoring The 17th International Conference on Solid-State Sensors, Actuators and Microsystems (Transducers '13) Barcelona, Spain, 16-20 June 2013 317
72. H. Ben-Yoav, T.E. Winkler, S.E. Chocron, G.R. Costa, S.M. Restaino, N. Woolsey, E. Kim, D.L. Kelly, G.F. Payne, and R. Ghodssi Towards personalized mental healthcare: An electrochemically-amplified biosensor for clozapine antipsychotic treatment monitoring The 17th International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS 2013) Freiburg, Germany, 27-31 October 2013 1167
73. I. Locatelli, A. Mrhar, and I. Grabnar Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection J. Pharmaceut. Biomed. 50 2009 905
74. D. Merli, D. Dondi, M. Pesavento, and A. Profumo Electrochemistry of olanzapine and risperidone at carbon nanotubes modified gold electrode through classical and DFT approaches J. Electroanal. Chem. 683 2012 103
75. B. Bhushan Springer Handbook of Nanotechnology 3rd ed. 2010 Springer
76. Y.H. Ghallab, and W. Badawy Lab-on-a-Chip: Techniques, Circuits, and Biomedical Applications 2010 Artech House
77. R. Mariella Sample preparation: the weak link in microfluidics-based biodetection Biomed. Microdevices 10 2008 777